For patients with normal glucose-6-phosphate dehydrogenase activity in malaria-endemic areas where frequent relapsing strains of Plasmodium vivax are prevalent, a 7-day high-dose course of primaquine was noninferior to a 14-day course.
A Connecticut resident has died from eastern equine encephalitis (EEE), the first such death in the state since 2013.
Two new human cases of mosquito-borne Eastern equine encephalitis were confirmed by the Massachusetts Department of Public Health.
Dozens of communities at high or moderate risk for Eastern equine encephalitis
Eli Lilly was the only pharmaceutical company providing quinidine gluconate in the United States, but in November 2017 it stopped manufacturing the drug and the remaining supplies expired.
In patients with malaria who have normal levels of glucose-6-phosphate dehydrogenase, 7-day primaquine was well tolerated and noninferior to 14-day primaquine.
A total of 2,813 cases of domestic arboviral disease were identified in 2018, of which 94% were West Nile Virus.
Dihydroartemisinin plus piperaquine for treating multidrug-resistant Plasmodium falciparum malaria should no longer be used in southeast Asia as a result of new resistance mutations.
The FDA has cleared for marketing the ZEUS Borrelia Modified Two-Tiered Testing algorithm to help in the diagnosis of Lyme disease.
Several sentinel chickens in the same flock have tested positive for Eastern Equine Encephalitis infection thus increasing risk of transmission to humans.
This is the first study to describe persistent joint pain and stiffness many months after infection with the chikungunya virus.
High-resolution maps of Plasmodium falciparum malaria informs where malaria elimination efforts should be strengthened by highlighting where burden remains high.
The CDC has summarized present and updated guidelines on dengue and Zika virus diagnostic testing in patients with a clinically compatible illness who live in or recently traveled to an endemic area.
Although most providers are familiar with the symptoms of Lyme disease, coinfection with other tickborne illnesses such as babesiosis, human granulocytic anaplasmosis, and human monocytic ehrlichiosis is possible and becoming more prevalent.
In an investigation of Lyme disease risk in the urban setting of New York City, forest parks with vegetated buffers and increased connectivity had higher Ixodes scapularis nymph densities, and the degree of connectivity strongly determined Borrelia burgdorferi nymphal infection prevalence, according to data published in Emerging Infectious Diseases. Because most tickborne disease studies in…
Powassan virus is emerging in the United States. We made a primer for your patients.
Seventy percent of rabies infections acquired in the United States attributed to bats
A 3-day course of either 300 mcg/kg/day or 600 mcg/kg/day of ivermectin may have similar mosquitocidal effects for up to 28-days postfeeding via membrane or direct skin feeding.
The Food and Drug Administration (FDA) has approved Dengvaxia (dengue tetravalent vaccine, live; Sanofi) for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4.
Significant changes may have occurred in France, in the population that developed malaria after travel in endemic areas, which implies that preventative strategies need to be adapted.